The Balance in Clinical Practice in 2023

In real life, in routine clinical practice today, you guys are not treating smoldering myeloma. Do it's high risk or low risk, or are you treating them outside of a clinical trial? Yeah. So if it's a high risk smoldering patient, I usually talk to the patient at length, tell them about the two randomized trials that show pretty significant reduction in risk of progression. And then figure out what would be the appropriate approach based on where their mentality is.